A more reliable prognosis for prostate cancer

With Prostatype, you can give your patient a more reliable medical opinion. Through unique gene analysis, the test provides clearer answers and a more reliable measure of how aggressive the prostate cancer is. You will receive additional documentation that facilitates the decision on treatment.

A more reliable treatment decision with gene expression

New conditions

Prostatype was developed by researchers at Karolinska Institutet and developed to provide more reliable measures of how aggressive a prostate cancer is. The test improves the ability to predict survival and provides a more reliable answer as to whether treatment is needed or not.

The test analyzes the expression of genes in cancer cells from prostate tissue. Together with Gleason, PSA value and tumor stage, Prostatype then calculates a P-score; a more reliable measure of how aggressive prostate cancer is.

A more reliable statement

Prostate cancer is the most common form of cancer in Sweden. In some cases it is difficult to detect when it is aggressive and should be treated, and in many cases we treat with surgery without it being necessary. It is difficult to determine with certainty how serious a prostate cancer is and many surgeries cause serious side effects.

With Prostatype, you can give your patient a more reliable statement. The result provides a more accurate basis and an additional basis for a second opinion. You as a doctor get better control over the patient’s diagnosis and an important piece of the puzzle before the important decision about the patient’s treatment.

How to order Prostatype

As a treating urologist, you can order the test using the following order form:

Patient information and consent form:

Due to sensitive patient data, the forms need to be sent by post to Prostatype.

Prostatype Genomics AB
Industrivägen 19
171 48 Solna
Sweden

Summary

Read more about the background to Prostatype, about the development of the test and what studies about the test have shown for results.

P-score Login

Log in here to create your P-score report.

New user: Contact support@prostatypegenomics.com for login information.

A more reliable treatment decision with gene expression

New conditions

Prostatype was developed by researchers at Karolinska Institutet and developed to provide more reliable measures of how aggressive a prostate cancer is. The test improves the ability to predict survival and provides a more reliable answer as to whether treatment is needed or not.

The test analyzes the expression of genes in cancer cells from prostate tissue. Together with Gleason, PSA value and tumor stage, Prostatype then calculates a P-score; a more reliable measure of how aggressive prostate cancer is.

A more reliable statement

Prostate cancer is the most common form of cancer in Sweden. In some cases it is difficult to detect when it is aggressive and should be treated, and in many cases we treat with surgery without it being necessary. It is difficult to determine with certainty how serious a prostate cancer is and many surgeries cause serious side effects.

With Prostatype, you can give your patient a more reliable statement. The result provides a more accurate basis and an additional basis for a second opinion. You as a doctor get better control over the patient’s diagnosis and an important piece of the puzzle before the important decision about the patient’s treatment.

How to order Prostatype

As a treating urologist, you can order the test using the following order form:

Patient information and consent form:

Due to sensitive patient data, the forms need to be sent by post to Prostatype.

Prostatype Genomics AB
Industrivägen 19
171 48 Solna
Swedem

Summary

Read more about the background to Prostatype, about the development of the test and what studies about the test have shown for results.

P-score Login

Log in here to create your P-score report.

New user: Contact support@prostatypegenomics.com for login information.

Contact Us

Questions? Contact us directly

Fredrik Persson – CEO
+46(0)73-049 77 01
fredrik.persson@prostatypegenomics.com

Prostatype Genomics

Prostatype is developed and marketed by Prostatype Genomics AB.

Phone: +46(0)8-20 87 00
Mail: info@prostatypegenomics.com

Go to press releases

I want to be contacted

Do you have questions about Prostatype? We answer your questions and thoughts.

Kontakt Engelsk

Or call  +46(0)8-20 87 00